A Study of AZD0486 Monotherapy or in Combination with Other Anti-Cancer Agents for Mature B-Cell Malignancies

Trial Identifier: D7407C00001
Sponsor: AstraZeneca
Start Date: January 2025
Primary Completion Date: April 2031
Study Completion Date: April 2031

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations